Navigation Links
Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women
Date:6/1/2008

WellPoint's Health Outcomes Research Subsidiary HealthCore Presents Data on Contributing Factors and Steps that Could Be Taken to Improve Treatment of

Women with Breast Cancer and Reduce Disparities

INDIANAPOLIS, June 1 /PRNewswire-FirstCall/ -- HealthCore today presented a study [Abstract No: 6593] comparing treatment patterns and adherence to established treatment guidelines for newly diagnosed breast cancer patients at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. While previous research has shown a relationship between the African-American race and increased breast cancer mortality in the general population, HealthCore sought to understand why similarly increased rates exist even among African-American women with health insurance.

The study, funded by Amgen, analyzed administrative claims data and patient medical charts for more than 3,000 Blue Cross and Blue Shield of Georgia (BCBSGA) members who were diagnosed with breast cancer between January 2000 and August 2005. HealthCore chose to evaluate disparities in care among the insured population to help health plans and physicians identify opportunities and strategies to improve outcomes for women with breast cancer.

"Our data indicates that while significant disparities in care still exist between African-American and Caucasian women, steps can be taken to reduce these differences among the fully insured population," said Louise Short, M.D, MSc, lead investigator for the study and Director of HealthCore's Integrated Research Network.

HealthCore researchers found the factors predicting worse outcomes for African-American vs. Caucasian women with newly diagnosed breast cancer in a fully insured population were consistent with those factors identified by the current medical literature for the general population. The contributing factors HealthCore identified included: diagnosis at a younger age (49.4 vs. 52.4 years; p<0.01) and lat
'/>"/>

SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 Neurelis, Inc. ("Neurelis") ... to end the option held by Biotie to purchase ... development of NRL-1 (intranasal diazepam) for pediatric and adult ... Over the past year, Biotie has advanced the development ... for the pivotal clinical work required for NDA submission ...
(Date:7/10/2014)... NEWPORT NEWS, Virginia , 11. ... führender Hersteller von Kameras für die ... Brust (MBI/BSGI), hat heute die CE-Zulassung ... Mit dem CE-Zeichen kann Dilon das ... seinen Vertriebsbereich auf den Großteil der ...
(Date:7/10/2014)... Calif. , July 10, 2014  Breg, ... and services, has launched the FreeRunner™ knee brace ... who suffer from patella mal-tracking return to active ... differently than other braces, providing support when patients ... normally when they don,t. Patellofemoral issues ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... 14, 2012  The Consumer Healthcare Products Association (CHPA) ... into law House Bill 2263—anti-meth legislation authored by ... 23rd state to adopt real-time, stop-sale technology known ... The proven system—in a process similar ...
... SCHLIEREN-ZURICH, Switzerland, May 14, 2012 The ALS ... it has entered into collaboration with Neurotune ... Neuron or Lou Gehrig,s disease). (Photo: ... "Maintaining the health of motor neurons ...
Cached Medicine Technology:CHPA Applauds Arizona's Adoption Of HB 2263 2The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease 2The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease 3
(Date:7/13/2014)... According to a new market research ... Component (processor, GPU, DSP, connectivity), Technology Node (45nm-5nm), ... - Forecast and Analysis to 2014-2020", published by ... Market is expected to reach $61.70 Billion by ... 2014 to 2020. , Browse 71 market data ...
(Date:7/13/2014)... Serena Gordon HealthDay ... A new type of sensor for people with diabetes ... using saliva instead of blood, researchers report. Scientists at ... tested it using artificial saliva. It uses light, metal and ... sugar. "Everybody knows that diabetics have to prick their ...
(Date:7/13/2014)... 13, 2014 The federal court overseeing ... filed against Johnson & Johnson’s Ethicon, Inc. is ... is expected to get underway next month. According to ... District Court, Southern District of West Virginia on July ... August 7, 2014 at 3:00 p.m. July selection is ...
(Date:7/13/2014)... Recently, MyDressCity.com, one of the most popular ... has released its new range of elegant Quinceanera ... available at discounted prices. Worldwide clients can enjoy this ... the company’s online shop, there are plenty of beautiful ... with great materials. MyDressCity.com’s hot items are prom gowns, ...
(Date:7/13/2014)... A noninvasive optical imaging device developed at ... later occur in the brain and are a ... results from investigators conducting a clinical trial in ... July 15 in an oral presentation at the ... They also were invited by conference organizers to ...
Breaking Medicine News(10 mins):Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3
... Scientists at Duke University Medical Center may have solved the ... they say may renew interest in gold salts as a ... first used injections of gold salts in the early 1900s ... But treatment came at a high cost: The shots ...
... 22 With health,facilities across the country struggling ... Veterans Affairs (VA) are demonstrating leadership by,collaborating in ... the federal healthcare supply chain. Through the innovative ... and expanding their ongoing,initiatives to both standardize and ...
... of virus in the blood of an HIV-infected personhas ... quickly someone infected with HIV infection progresses to AIDS. ... work that suggests that several other factors in addition ... , Researchers led by Sunil Ahuja, M.D., of the ...
... , , MONDAY, Oct. 22 (HealthDay News) -- If you,re sneaking ... a common device can determine whether someone is a smoker. ... to ferret out people who hide a cigarette habit, ... patients what smoking is doing to their bodies, he added. ...
... vascular surgery, picks up size 7 crochet hooks from a fabric ... in a new technique he has developed to treat varicose veins. ... procedure, called light-assisted stab phlebectomy, or LASP, appear in a study ... , More than 250 patients at UCLA have ...
... Information,Systems (Nasdaq: MEDW ) announced today that ... licensed Mediware,s HCLL(TM) Transfusion,Management software system, which provides ... transfusion errors, improve patient,safety and maximize operational efficiency. ... is based in Dallas, Texas, and,through its subsidiaries, ...
Cached Medicine News:Health News:Scientists discover how gold eases pain of arthritis 2Health News:DoD and VA to Reduce Healthcare Supply Chain Costs 2Health News:DoD and VA to Reduce Healthcare Supply Chain Costs 3Health News:DoD and VA to Reduce Healthcare Supply Chain Costs 4Health News:Blood Test Catches Secret Smokers 2Health News:Blood Test Catches Secret Smokers 3Health News:UCLA doctor develops new technique to treat varicose veins 2Health News:UCLA doctor develops new technique to treat varicose veins 3Health News:Mediware's Transfusion Management Software Adopted by Four Additional Tenet Hospitals 2Health News:Mediware's Transfusion Management Software Adopted by Four Additional Tenet Hospitals 3
Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 50 OD...
Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Medicine Products: